File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1073/pnas.0712059105
- Scopus: eid_2-s2.0-41149097551
- PMID: 18250301
- WOS: WOS:000253261900046
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
Title | Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice |
---|---|
Authors | |
Keywords | Double positive thymocytes Senescence p27 Lymphomas Cyclin A |
Issue Date | 2008 |
Citation | Proceedings of the National Academy of Sciences of the United States of America, 2008, v. 105, n. 6, p. 2022-2027 How to Cite? |
Abstract | PTEN is a tumor suppressor gene but whether cancer can develop in all PTEN-deficient cells is not known. In T cell-specific PTEN-deficient (tPTEN -/-) mice, which suffer from mature T cell lymphomas, we found that premalignancy, as defined by elevated AKT and senescence pathways, starts in immature T cell precursors and surprisingly not in mature T cells. Premalignancy only starts in 6-week-old mice and becomes much stronger in 9-week-old mice although PTEN is lost since birth. tPTEN-/- immature T cells do not become tumors, and senescence has no role in this model because these cells exist in a novel cell cycle state, expressing proliferating proteins but not proliferating to any significant degree. Instead, the levels of p27 kip1, which is lower in tPTEN-/- immature T cells and almost nonexistent in tPTEN-/- mature T cells, correlate with the proliferation capability of these cells. Interestingly, transient reduction of these cancer precursor cells in adult tPTEN-/- mice within a crucial time window significantly delayed lymphomas and mouse lethality. Thus, loss of PTEN alone is not sufficient for cells to become cancerous, therefore other developmental events are necessary for tumor formation. © 2008 by The National Academy of Sciences of the USA. |
Persistent Identifier | http://hdl.handle.net/10722/291815 |
ISSN | 2023 Impact Factor: 9.4 2023 SCImago Journal Rankings: 3.737 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xue, Ling | - |
dc.contributor.author | Nolla, Hector | - |
dc.contributor.author | Suzuki, Akira | - |
dc.contributor.author | Mak, Tak W. | - |
dc.contributor.author | Winoto, Astar | - |
dc.date.accessioned | 2020-11-17T14:55:10Z | - |
dc.date.available | 2020-11-17T14:55:10Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Proceedings of the National Academy of Sciences of the United States of America, 2008, v. 105, n. 6, p. 2022-2027 | - |
dc.identifier.issn | 0027-8424 | - |
dc.identifier.uri | http://hdl.handle.net/10722/291815 | - |
dc.description.abstract | PTEN is a tumor suppressor gene but whether cancer can develop in all PTEN-deficient cells is not known. In T cell-specific PTEN-deficient (tPTEN -/-) mice, which suffer from mature T cell lymphomas, we found that premalignancy, as defined by elevated AKT and senescence pathways, starts in immature T cell precursors and surprisingly not in mature T cells. Premalignancy only starts in 6-week-old mice and becomes much stronger in 9-week-old mice although PTEN is lost since birth. tPTEN-/- immature T cells do not become tumors, and senescence has no role in this model because these cells exist in a novel cell cycle state, expressing proliferating proteins but not proliferating to any significant degree. Instead, the levels of p27 kip1, which is lower in tPTEN-/- immature T cells and almost nonexistent in tPTEN-/- mature T cells, correlate with the proliferation capability of these cells. Interestingly, transient reduction of these cancer precursor cells in adult tPTEN-/- mice within a crucial time window significantly delayed lymphomas and mouse lethality. Thus, loss of PTEN alone is not sufficient for cells to become cancerous, therefore other developmental events are necessary for tumor formation. © 2008 by The National Academy of Sciences of the USA. | - |
dc.language | eng | - |
dc.relation.ispartof | Proceedings of the National Academy of Sciences of the United States of America | - |
dc.subject | Double positive thymocytes | - |
dc.subject | Senescence | - |
dc.subject | p27 | - |
dc.subject | Lymphomas | - |
dc.subject | Cyclin A | - |
dc.title | Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1073/pnas.0712059105 | - |
dc.identifier.pmid | 18250301 | - |
dc.identifier.pmcid | PMC2538875 | - |
dc.identifier.scopus | eid_2-s2.0-41149097551 | - |
dc.identifier.volume | 105 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 2022 | - |
dc.identifier.epage | 2027 | - |
dc.identifier.eissn | 1091-6490 | - |
dc.identifier.isi | WOS:000253261900046 | - |
dc.identifier.issnl | 0027-8424 | - |